Skip to main content
Top
Published in: Journal of Gastroenterology 9/2017

01-09-2017 | Original Article—Liver, Pancreas, and Biliary Tract

Natural history of chronic hepatitis B virus infection in children in Japan: a comparison of mother-to-child transmission with horizontal transmission

Authors: Tomoko Takano, Hitoshi Tajiri, Satoyo Hosono, Ayano Inui, Jun Murakami, Kosuke Ushijima, Yoko Miyoshi, Yuri Etani, Daiki Abukawa, Mitsuyoshi Suzuki, Stephen Brooks

Published in: Journal of Gastroenterology | Issue 9/2017

Login to get access

Abstract

Background

It is necessary to evaluate the natural history of children with hepatitis B virus (HBV) infection in each country to consider their long-term management.

Methods

A multi-center observational study of children with chronic HBV infection who were diagnosed at age ≤15 years was carried out in 18 hospitals in Japan.

Results

We reviewed children with HBV infection including 381 with mother-to-child transmission (MTCT) and 154 with horizontal transmission, genotype C being the most prevalent virus genotype (83%). Children with horizontal transmission were more frequently infected with HBV genotype A or B and more likely to receive interferon therapy than those infected by MTCT. The HBeAg seroconversion rate at 15 years of age was 42% in the MTCT group and 38% in the horizontal group. It was lower in children with genotype C infection than in those infected with other genotypes (33 versus 45%). Hepatitis developed at any age but before 4 years of age the incidence was high in the horizontal group. At 3 years after the onset of the hepatitis, 26% of children with MTCT and 30% of those with horizontal transmission became inactive carriers. The incidences of hepatocellular carcinoma (HCC) at 30 years of age were 6% in the MTCT group and 11% in the horizontal group.

Conclusions

Patients with childhood-onset HBV infection with MTCT and horizontal transmission developed hepatitis and seroconverted to anti-HBe at any age and had a lifetime risk of developing HCC.
Literature
1.
go back to reference Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97–107.CrossRefPubMed Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97–107.CrossRefPubMed
2.
go back to reference Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48:335–52.CrossRefPubMed Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48:335–52.CrossRefPubMed
3.
go back to reference Koyama T, Matsuda I, Sato S, et al. Prevention of perinatal hepatitis B virus transmission by combined passive active immunoprophylaxis in Iwate, Japan (1981–1992) and epidemiological evidence for its efficacy. Hepatol Res. 2003;26:287–92.CrossRefPubMed Koyama T, Matsuda I, Sato S, et al. Prevention of perinatal hepatitis B virus transmission by combined passive active immunoprophylaxis in Iwate, Japan (1981–1992) and epidemiological evidence for its efficacy. Hepatol Res. 2003;26:287–92.CrossRefPubMed
4.
go back to reference Tajiri H, Tanaka Y, Kagimoto S, et al. Molecular evidence of father-to-child transmission of hepatitis B virus. J Med Virol. 2007;79:922–6.CrossRefPubMed Tajiri H, Tanaka Y, Kagimoto S, et al. Molecular evidence of father-to-child transmission of hepatitis B virus. J Med Virol. 2007;79:922–6.CrossRefPubMed
5.
go back to reference Aomatsu T, Komatsu H, Yoden A, et al. Fulminant hepatitis B and acute hepatitis B due to intrafamilial transmission of HBV after chemotherapy for non-Hodgkin’s lymphoma in an HBV carrier. Eur J Pediatr. 2010;169:167–71.CrossRefPubMed Aomatsu T, Komatsu H, Yoden A, et al. Fulminant hepatitis B and acute hepatitis B due to intrafamilial transmission of HBV after chemotherapy for non-Hodgkin’s lymphoma in an HBV carrier. Eur J Pediatr. 2010;169:167–71.CrossRefPubMed
6.
go back to reference Sugauchi F, Orito E, Ohno T, et al. Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan. Hepatol Res. 2006;36:107–14.CrossRefPubMed Sugauchi F, Orito E, Ohno T, et al. Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan. Hepatol Res. 2006;36:107–14.CrossRefPubMed
7.
go back to reference Ito K, Yotsuyanagi H, Yatsuhashi H, et al. Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology. 2014;59:89–97.CrossRefPubMed Ito K, Yotsuyanagi H, Yatsuhashi H, et al. Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology. 2014;59:89–97.CrossRefPubMed
8.
go back to reference Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science. 1993;262:369–70.CrossRefPubMed Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science. 1993;262:369–70.CrossRefPubMed
9.
go back to reference Lok AS. Natural history and control of perinatally acquired hepatitis B virus infection. Dig Dis. 1992;10:46–52.CrossRefPubMed Lok AS. Natural history and control of perinatally acquired hepatitis B virus infection. Dig Dis. 1992;10:46–52.CrossRefPubMed
11.
go back to reference Liaw YF. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int. 2009;29:100–7.CrossRefPubMed Liaw YF. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int. 2009;29:100–7.CrossRefPubMed
12.
go back to reference Della Corte C, Nobili V, Comparcola D, et al. Management of chronic hepatitis B in children: an unresolved issue. J Gastroenterol Hepatol. 2014;29:912–9.CrossRefPubMed Della Corte C, Nobili V, Comparcola D, et al. Management of chronic hepatitis B in children: an unresolved issue. J Gastroenterol Hepatol. 2014;29:912–9.CrossRefPubMed
13.
go back to reference Livingston SE, Simonetti JP, Bulkow LR, et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology. 2007;133:1452–7.CrossRefPubMed Livingston SE, Simonetti JP, Bulkow LR, et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology. 2007;133:1452–7.CrossRefPubMed
14.
go back to reference Ni YH, Chang MH, Wang KJ, et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology. 2004;127:1733–8.CrossRefPubMed Ni YH, Chang MH, Wang KJ, et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology. 2004;127:1733–8.CrossRefPubMed
15.
go back to reference Croagh CM, Desmond PV, Bell SJ. Genotypes and viral variants in chronic hepatitis B: a review of epidemiology and clinical relevance. World J Hepatol. 2015;7:289–303.CrossRefPubMedPubMedCentral Croagh CM, Desmond PV, Bell SJ. Genotypes and viral variants in chronic hepatitis B: a review of epidemiology and clinical relevance. World J Hepatol. 2015;7:289–303.CrossRefPubMedPubMedCentral
16.
go back to reference Lin CL, Kao JH. Hepatitis B virus genotypes and variants. Cold Spring Harb Perspect Med. 2015;5:1–9. Lin CL, Kao JH. Hepatitis B virus genotypes and variants. Cold Spring Harb Perspect Med. 2015;5:1–9.
17.
go back to reference Kimura A, Matsuyuki M, Yuge K, et al. Natural history of Japanese children with chronic hepatitis B: seroconversion from HBeAg to anti-HBe. Acta Paediatr Jpn. 1993;35:537–40.CrossRefPubMed Kimura A, Matsuyuki M, Yuge K, et al. Natural history of Japanese children with chronic hepatitis B: seroconversion from HBeAg to anti-HBe. Acta Paediatr Jpn. 1993;35:537–40.CrossRefPubMed
18.
go back to reference Komatsu H, Inui A, Sogo T, et al. Chronic hepatitis B virus infection in children and adolescents in Japan. J Pediatr Gastroenterol Nutr. 2015;60:99–104.CrossRefPubMed Komatsu H, Inui A, Sogo T, et al. Chronic hepatitis B virus infection in children and adolescents in Japan. J Pediatr Gastroenterol Nutr. 2015;60:99–104.CrossRefPubMed
19.
go back to reference Takano T, Tajiri H, Etani Y, et al. Natural history of chronic hepatitis B virus infection in childhood and efficacy of interferon therapy. Scand J Gastroenterol. 2015;50:892–9.CrossRefPubMed Takano T, Tajiri H, Etani Y, et al. Natural history of chronic hepatitis B virus infection in childhood and efficacy of interferon therapy. Scand J Gastroenterol. 2015;50:892–9.CrossRefPubMed
20.
go back to reference Popalis C, Yeung LT, Ling SC, et al. Chronic hepatitis B virus (HBV) infection in children: 25 years’ experience. J Viral Hepat. 2013;20:e20–6.CrossRefPubMed Popalis C, Yeung LT, Ling SC, et al. Chronic hepatitis B virus (HBV) infection in children: 25 years’ experience. J Viral Hepat. 2013;20:e20–6.CrossRefPubMed
21.
go back to reference Zacharakis G, Koskinas J, Kotsiou S, et al. Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years’ follow-up in northern Greece. J Pediatr Gastroenterol Nutr. 2007;44:84–91.CrossRefPubMed Zacharakis G, Koskinas J, Kotsiou S, et al. Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years’ follow-up in northern Greece. J Pediatr Gastroenterol Nutr. 2007;44:84–91.CrossRefPubMed
22.
go back to reference Jonas MM, Block JM, Haber BA, et al. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology. 2010;52:2192–205.CrossRefPubMed Jonas MM, Block JM, Haber BA, et al. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology. 2010;52:2192–205.CrossRefPubMed
23.
go back to reference Sugauchi S, Mizokami M, Orito E, et al. A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol. 2001;82:883–92.CrossRefPubMed Sugauchi S, Mizokami M, Orito E, et al. A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol. 2001;82:883–92.CrossRefPubMed
24.
go back to reference Sugauchi F, Orito E, Ichida T, et al. Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J Virol. 2002;76:5985–92.CrossRefPubMedPubMedCentral Sugauchi F, Orito E, Ichida T, et al. Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J Virol. 2002;76:5985–92.CrossRefPubMedPubMedCentral
25.
go back to reference le Lee Y, Aw M, Rauff M, et al. Hepatitis B immunoprophylaxis failure and the presence of hepatitis B surface gene mutants in the affected children. J Med Virol. 2015;87:1344–50.CrossRefPubMed le Lee Y, Aw M, Rauff M, et al. Hepatitis B immunoprophylaxis failure and the presence of hepatitis B surface gene mutants in the affected children. J Med Virol. 2015;87:1344–50.CrossRefPubMed
26.
go back to reference Zou H, Chen Y, Duan Z, et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat. 2012;19:e18–25.CrossRefPubMed Zou H, Chen Y, Duan Z, et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat. 2012;19:e18–25.CrossRefPubMed
27.
go back to reference Chu CM, Liaw YF. Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion. J Viral Hepat. 2007;14:147–52.CrossRefPubMed Chu CM, Liaw YF. Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion. J Viral Hepat. 2007;14:147–52.CrossRefPubMed
28.
go back to reference Kao JH, Chen PJ, Lai MY, et al. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology. 2000;118:554–9.CrossRefPubMed Kao JH, Chen PJ, Lai MY, et al. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology. 2000;118:554–9.CrossRefPubMed
29.
go back to reference Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst. 2005;97:265–72.CrossRefPubMed Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst. 2005;97:265–72.CrossRefPubMed
Metadata
Title
Natural history of chronic hepatitis B virus infection in children in Japan: a comparison of mother-to-child transmission with horizontal transmission
Authors
Tomoko Takano
Hitoshi Tajiri
Satoyo Hosono
Ayano Inui
Jun Murakami
Kosuke Ushijima
Yoko Miyoshi
Yuri Etani
Daiki Abukawa
Mitsuyoshi Suzuki
Stephen Brooks
Publication date
01-09-2017
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 9/2017
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-017-1315-4

Other articles of this Issue 9/2017

Journal of Gastroenterology 9/2017 Go to the issue